Discovery Pipeline

Can Vaccine Development Be Safely Accelerated?

April 01, 2020

Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe.

PMI Biopharma Solutions, Nashville Biosciences Partner on Comprehensive Drug Discovery

March 27, 2020

The strategic alliance provides an integrated product offering around drug discovery and development.

Gene-Editing Techniques Target New Applications

August 01, 2019

Experts explore the role gene-editing techniques can play in regenerative medicine and cell-line development.

Gilead, AbCellera in Therapeutic Antibody Discovery Collaboration

June 13, 2019

In this collaboration, AbCellera will apply its expertise to generate panels of antibody candidates for Gilead to evaluate.

New Compound Discovered that Kills Antibiotic-Resistant Microbes

May 28, 2019

Researchers at the University of Sheffield, Sheffield, UK, have discovered and developed a new compound that can kill antibiotic-resistant bacteria, including Escherichia coli.

AstraZeneca, BenevolentAI Partner on AI for Drug Discovery

May 01, 2019

The companies will join forces to use artificial intelligence (AI) and machine learning to discover and develop new treatments for two chronic diseases.

Valitacell, Solentim Collaborate to Accelerate Development of Breakthrough Medicines

February 22, 2019

Valitacell and Solentim, have announced a collaboration aimed at the acceleration of discovery and development of biologic drugs and advanced cell therapies.

Gene Therapy Holds Promise for Blood Disorders

January 11, 2019

Researchers at the University of Delaware have made a step forward in gene therapy by engineering microparticles that deliver gene-regulating material to hematopoietic stem and progenitor cells, which live deep in bone marrow and direct the formation of blood cells.

Brain Glial Cells Reprogrammed into Working Neurons

January 11, 2019

A new gene therapy can turn certain brain glial cells into functioning neurons, which could help repair the brain after a stroke or during neurological disorders like Alzheimer’s or Parkinson’s diseases, according to researchers at Penn State.

Scientists Isolate mAbs That Neutralize GI Virus

September 14, 2018

Researchers at Vanderbilt University Medical Center have isolated the first human monoclonal antibodies (mAbs) that can neutralize norovirus, a virus that causes acute gastrointestinal (GI) illness.